Latest dermatitis Stories
DUBLIN, March 20, 2015 /PRNewswire/ -- Dignity Sciences (DS) is today presenting a late-breaking news abstract at the annual meeting of the American Association of Dermatology
TARRYTOWN, N.Y. and PARIS, Nov. 20, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.
The Canadian based disinfectant manufacturer wants to help dairy farmers and bovine health professionals learn more about hoof care. SHERBROOKE, QC, Oct.
TARRYTOWN, N.Y. and PARIS, Oct. 20, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Margo Weaver, a Florida-based author, has released a new book aimed at helping children suffering from eczema to become more comfortable in their skin. APOPKA,
An investigational medication shows promise in treating the most common skin disorder, often referred to as eczema or atopic dermatitis.
Results from Earlier Clinical Trials Published Today in the New England Journal of Medicine TARRYTOWN, N.Y. and PARIS, July 9, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Dignity Sciences Limited finds that a DGLA topical cream (DS107E) has an overall dose response improvement for Atopic Dermatitis in a Phase II clinical trial. Dublin,
-- Latest psychological research reveals rosacea redness creates negative first impressions putting sufferers at a disadvantage -- Rosacea remains under-diagnosed, yet diagnosis
Health Canada Approves The First and Only Topical Treatment Indicated for the Persistent Facial Erythema of Rosacea THORNHILL, ON, May 21, 2014 /CNW/ - Galderma Canada Inc.,
- Growing in low tufty patches.